Advanced Medical Solutions Group plc announced that it has received CE approval to market and launch its LiquiBandFix8 Open Hernia Mesh Fixation Device in Europe. The LiquiBandFix8 Open Hernia Mesh Fixation Device is used for atraumatic mesh fixation in open inguinal hernia surgery. The device optimises costs for payors due to the reduced turnaround time of patients without compromising patient care. The device will be marketed and distributed by the Group's direct sales teams in the UK and Germany and through various distributor partners across the EU. This approval augments AMS's existing LiquiBandFix8 laparoscopic fixation device already used in minimally invasive hernia repair. At present, the laparoscopic device is approved for use in Europe and a number of other markets. AMS has begun the US approval process for the laparoscopic fixation device which is expected to take another two years and to cost approximately £3 million as it will necessitate a full set of clinical trials. These are expected to start early next year, once Investigational Device Exemption with the FDA has been obtained.